These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 24799619)

  • 1. A PET Tracer for Brain α2C Adrenoceptors, (11)C-ORM-13070: Radiosynthesis and Preclinical Evaluation in Rats and Knockout Mice.
    Arponen E; Helin S; Marjamäki P; Grönroos T; Holm P; Löyttyniemi E; Någren K; Scheinin M; Haaparanta-Solin M; Sallinen J; Solin O
    J Nucl Med; 2014 Jul; 55(7):1171-7. PubMed ID: 24799619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiosynthesis and Preclinical Evaluation of an α
    Krzyczmonik A; Keller T; López-Picón FR; Forsback S; Kirjavainen AK; Takkinen JS; Wasilewska A; Scheinin M; Haaparanta-Solin M; Sączewski F; Solin O
    Mol Imaging Biol; 2019 Oct; 21(5):879-887. PubMed ID: 30710261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ¹¹C-ORM-13070, a novel PET ligand for brain α₂C-adrenoceptors: radiometabolism, plasma pharmacokinetics, whole-body distribution and radiation dosimetry in healthy men.
    Luoto P; Suilamo S; Oikonen V; Arponen E; Helin S; Herttuainen J; Hietamäki J; Holopainen A; Kailajärvi M; Peltonen JM; Rouru J; Sallinen J; Scheinin M; Virta J; Virtanen K; Volanen I; Roivainen A; Rinne JO
    Eur J Nucl Med Mol Imaging; 2014 Oct; 41(10):1947-56. PubMed ID: 24838249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of [(11) C]ORM-13070 as a PET tracer for alpha2c -adrenoceptors in the human brain.
    Lehto J; Hirvonen MM; Johansson J; Kemppainen J; Luoto P; Naukkarinen T; Oikonen V; Arponen E; Rouru J; Sallinen J; Scheinin H; Vuorilehto L; Finnema SJ; Halldin C; Rinne JO; Scheinin M
    Synapse; 2015 Mar; 69(3):172-81. PubMed ID: 25530024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amphetamine decreases α2C-adrenoceptor binding of [11C]ORM-13070: a PET study in the primate brain.
    Finnema SJ; Hughes ZA; Haaparanta-Solin M; Stepanov V; Nakao R; Varnäs K; Varrone A; Arponen E; Marjamäki P; Pohjanoksa K; Vuorilehto L; Babalola PA; Solin O; Grimwood S; Sallinen J; Farde L; Scheinin M; Halldin C
    Int J Neuropsychopharmacol; 2014 Dec; 18(3):. PubMed ID: 25522417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Test-retest reliability of (11)C-ORM-13070 in PET imaging of α2C-adrenoceptors in vivo in the human brain.
    Lehto J; Virta JR; Oikonen V; Roivainen A; Luoto P; Arponen E; Helin S; Hietamäki J; Holopainen A; Kailajärvi M; Peltonen JM; Rouru J; Sallinen J; Virtanen K; Volanen I; Scheinin M; Rinne JO
    Eur J Nucl Med Mol Imaging; 2015 Jan; 42(1):120-7. PubMed ID: 25201008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiosynthesis and preclinical evaluation of 11C-ABP688 as a probe for imaging the metabotropic glutamate receptor subtype 5.
    Ametamey SM; Kessler LJ; Honer M; Wyss MT; Buck A; Hintermann S; Auberson YP; Gasparini F; Schubiger PA
    J Nucl Med; 2006 Apr; 47(4):698-705. PubMed ID: 16595505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biodistribution of [11C]R107474, a new radiolabeled alpha2-adrenoceptor antagonist.
    Van der Mey M; Windhorst AD; Klok RP; Herscheid JD; Kennis LE; Bischoff F; Bakker M; Langlois X; Heylen L; Jurzak M; Leysen JE
    Bioorg Med Chem; 2006 Jul; 14(13):4526-34. PubMed ID: 16517171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of the PET ligand [
    Shahid M; Rinne JO; Scheinin M; Virta J; Marjamäki P; Solin O; Arponen E; Sallinen J; Kuokkanen K; Rouru J
    EJNMMI Res; 2020 Dec; 10(1):152. PubMed ID: 33296042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterisation of a structurally novel α2C-adrenoceptor antagonist ORM-10921 and its effects in neuropsychiatric models.
    Sallinen J; Holappa J; Koivisto A; Kuokkanen K; Chapman H; Lehtimäki J; Piepponen P; Mijatovic J; Tanila H; Virtanen R; Sirviö J; Haapalinna A
    Basic Clin Pharmacol Toxicol; 2013 Oct; 113(4):239-49. PubMed ID: 23718812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and pharmacological evaluation of ¹¹C-labeled piperazine derivative as a PET probe for sigma-2 receptor imaging.
    Selivanova SV; Toscano A; Abate C; Berardi F; Müller A; Krämer SD; Schibli R; Ametamey SM
    Nucl Med Biol; 2015 Apr; 42(4):399-405. PubMed ID: 25637276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiosynthesis and evaluation of new α1-adrenoceptor antagonists as PET radioligands for brain imaging.
    Airaksinen AJ; Finnema SJ; Balle T; Varnäs K; Bang-Andersen B; Gulyás B; Farde L; Halldin C
    Nucl Med Biol; 2013 Aug; 40(6):747-54. PubMed ID: 23810488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of [11C]MK-912 as an alpha2-adrenergic receptor radioligand for PET studies.
    Shiue C; Pleus RC; Shiue GG; Rysavy JA; Sunderland JJ; Cornish KG; Young SD; Bylund DB
    Nucl Med Biol; 1998 Feb; 25(2):127-33. PubMed ID: 9468027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detecting a dexmedetomidine-evoked reduction of noradrenaline release in the human brain with the alpha2C-adrenoceptor PET ligand [11C]ORM-13070.
    Lehto J; Scheinin A; Johansson J; Marjamäki P; Arponen E; Scheinin H; Scheinin M
    Synapse; 2016 Feb; 70(2):57-65. PubMed ID: 26562363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiosynthesis and in vivo evaluation of novel radioligands for PET imaging of cerebral 5-HT7 receptors.
    Hansen HD; Herth MM; Ettrup A; Andersen VL; Lehel S; Dyssegaard A; Kristensen JL; Knudsen GM
    J Nucl Med; 2014 Apr; 55(4):640-6. PubMed ID: 24566002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and initial PET imaging of new potential NK1 receptor radioligands 1-[2-(3,5-bis-trifluoromethyl-benzyloxy)-1-phenyl-ethyl]-4-[11C]methyl-piperazine and {4-[2-(3,5-bis-trifluoromethyl-benzyloxy)-1-phenyl-ethyl]-piperazine-1-yl}-acetic acid [11C]methyl ester.
    Gao M; Mock BH; Hutchins GD; Zheng QH
    Nucl Med Biol; 2005 Jul; 32(5):543-52. PubMed ID: 15982585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical evaluation of new C-11 labeled benzo-1,4-dioxane PET radiotracers for brain α2C adrenergic receptors.
    Alluri S; Eisenberg SM; Grisanti LA; Tanner M; Volkow ND; Kim SW; Kil KE
    Eur J Med Chem; 2022 Dec; 243():114764. PubMed ID: 36272201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiosynthesis, photoisomerization, biodistribution, and metabolite analysis of 11C-PBB3 as a clinically useful PET probe for imaging of tau pathology.
    Hashimoto H; Kawamura K; Igarashi N; Takei M; Fujishiro T; Aihara Y; Shiomi S; Muto M; Ito T; Furutsuka K; Yamasaki T; Yui J; Xie L; Ono M; Hatori A; Nemoto K; Suhara T; Higuchi M; Zhang MR
    J Nucl Med; 2014 Sep; 55(9):1532-8. PubMed ID: 24963128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of carbon-11 and fluorine-18 labeled tracers for in vivo visualization of PDE10A.
    Ooms M; Celen S; Koole M; Langlois X; Schmidt M; De Angelis M; Andrés JI; Verbruggen A; Van Laere K; Bormans G
    Nucl Med Biol; 2014 Sep; 41(8):695-704. PubMed ID: 25002365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiosynthesis and evaluation of [11C]YM-202074 as a PET ligand for imaging the metabotropic glutamate receptor type 1.
    Yanamoto K; Konno F; Odawara C; Yamasaki T; Kawamura K; Hatori A; Yui J; Wakizaka H; Nengaki N; Takei M; Zhang MR
    Nucl Med Biol; 2010 Jul; 37(5):615-24. PubMed ID: 20610166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.